Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 253.00 | 238.25 | 1.0619 | 1.2608 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 3.00 | 238.25 | 0.0126 | -0.9997 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 2.00 | 238.25 | 0.0084 | -0.9999 | |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 244.00 | 238.25 | 1.0241 | 1.0997 | |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 312.50 | 169.63 | 153.00 | 238.25 | 0.6422 | -0.1898 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 312.50 | 169.63 | 131.00 | 238.25 | 0.5498 | -0.4097 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 312.50 | 169.63 | 131.00 | 238.25 | 0.5498 | -0.4097 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 312.50 | 169.63 | 235.00 | 238.25 | 0.9864 | 0.9447 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 312.50 | 169.63 | 202.00 | 238.25 | 0.8479 | 0.4282 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 312.50 | 169.63 | 228.00 | 238.25 | 0.9570 | 0.8284 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 312.50 | 169.63 | 195.00 | 238.25 | 0.8185 | 0.3290 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 312.50 | 169.63 | 153.00 | 238.25 | 0.6422 | -0.1898 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 312.50 | 169.63 | 294.00 | 238.25 | 1.2340 | 2.0714 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 261.00 | 238.25 | 1.0955 | 1.4090 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 312.50 | 169.63 | 352.00 | 238.25 | 1.4774 | 3.4348 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 312.50 | 169.63 | 342.00 | 238.25 | 1.4355 | 3.1816 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 312.50 | 169.63 | 269.00 | 238.25 | 1.1291 | 1.5621 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 312.50 | 169.63 | 256.00 | 238.25 | 1.0745 | 1.3158 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 312.50 | 169.63 | 253.00 | 238.25 | 1.0619 | 1.2608 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 312.50 | 169.63 | 164.00 | 238.25 | 0.6884 | -0.0665 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 312.50 | 169.63 | 155.00 | 238.25 | 0.6506 | -0.1680 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 201.00 | 238.25 | 0.8437 | 0.4138 | |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 312.50 | 169.63 | 273.00 | 238.25 | 1.1459 | 1.6404 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 312.50 | 169.63 | 211.00 | 238.25 | 0.8856 | 0.5610 |
| SK-BR-3 | 0 | uM | 7 | 312.50 | 169.63 | 255.00 | 238.25 | 1.0703 | 1.2974 |